SCHEMBL10151655

SCHEMBL10151655

C#CC1(C)C(=O)Nc2cc(C)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.42
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
ADAMTS5 Q9UNA0 3/20 0.37
MMP12 P39900 1/20 0.35
CSNK1G1 Q9HCP0 1/20 0.34
GAA P10253 3/20 0.34
MGAM O43451 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
PDK2 Q15119 1/20 0.33
PDK4 Q16654 1/20 0.33
BRD4 O60885 1/20 0.33
ROS1 P08922 1/20 0.33
CDK5 Q00535 1/20 0.33
ACVR1 Q04771 1/20 0.33
LRRK2 Q5S007 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433946 0.77 PDK2 (0.57) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL23972238 0.74 AKR1B1 (0.45) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL11225066 0.72 CYP1A2 (0.51) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL12782420 0.72 AKR1B1 (0.46) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL13825600 0.71 AKR1B1 (0.43) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL24029215 0.71 AKR1B1 (0.43) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL25805362 0.71 AKR1B1 (0.43) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL23835847 0.71 AKR1B1 (0.43) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL21626819 0.70 BACE1 (0.51) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL5975458 0.69 MAPK14 (0.53) CYP1A2POLBCYP3A4CYP2C19MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1955697-B1 2-AMINOBENZAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) INHIBITORS USEFUL FOR THE TREATMENT OF PAIN OR BLADDER FUNCTION DISORDER ASTELLAS PHARMA INC (JP) 2012-05-02 EP disclosed